Arovella Therapeutics Ltd News

Arovella Therapeutics Ltd: Notice Under Section 708A

Oct 17 19:15 ET

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Oct 17 19:13 ET

Arovella Therapeutics Ltd: Clinical Advisory Board established

Oct 13 18:47 ET

Arovella Therapeutics Ltd: Updated Investor Webinar Presentation

Sep 12 03:18 ET

Arovella Therapeutics Ltd: Investor Webinar Presentation

Sep 11 23:27 ET

Arovella Therapeutics Ltd: 2024 ESG Report

Sep 10 20:32 ET

Arovella Therapeutics Ltd: Corporate Governance Statement

Aug 21 19:46 ET

Arovella Therapeutics Ltd: Appendix 4G

Aug 21 19:44 ET

Arovella Therapeutics Ltd: Positive pre-IND feedback from FDA for ALA-101

Aug 6 19:21 ET

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 24 19:34 ET

Arovella Therapeutics Ltd: Zolpimist Update

Jun 12 18:24 ET

Arovella Therapeutics Ltd: Arovella completes manufacturing scale-up

Jun 4 19:16 ET

Arovella Therapeutics Ltd: Release of Shares from Escrow

May 29 18:27 ET

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 19:51 ET

Arovella Therapeutics Ltd: Arovella presents ALA-101 data at AACR

Apr 8 18:56 ET

Arovella Therapeutics Ltd: Prof Gianpietro Dotti appointed to Scientific Advisory Board

Apr 2 19:18 ET

Arovella Therapeutics Ltd: Change of Director's Interest Notice - GP

Apr 2 17:28 ET

Arovella Therapeutics Ltd: Change of Director's Interest Notice - TD

Apr 1 17:31 ET

Arovella Therapeutics Ltd: Change of Director's Interest Notice - MB

Mar 27 18:49 ET

Arovella Therapeutics Ltd: Arovella to present at AACR annual meeting

Mar 26 19:55 ET